Pivotal trial of a biodegradable stent for patients with refractory benign esophageal stricture

ConclusionThe BDS was effective for refractory BES and the safety was acceptable. However, the indication for this procedure in patients RECEIVING CRT for esophageal cancer should be carefully considered.
Source: Esophagus - Category: Gastroenterology Source Type: research